Biogen and Eisai release new Alzheimer’s drug data that may support wider uptake By: MarketWatch October 25, 2023 at 17:28 PM EDT Eisai plans to apply for FDA approval of subcutaneous Leqembi by early next year. Read More >> Related Stocks: Biogen Idec Eisai Co. Ltd Eli Lilly
